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Differential Requirements for DOCK2
and Phosphoinositide-3-Kinase 
during T and B Lymphocyte Homing
Mackay, 2000). Chemokines are small, secreted poly-
peptides which, together with adhesion receptors, or-
chestrate physiological lymphocyte homing (Cyster,
1999; von Andrian and Mackay, 2000). A well-studied
example are the homeostatic chemokines CCL19 and
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ally requires 47 and its ligand MAdCAM-1 (von AndrianSaitama 332-0012
and Mackay, 2000). VLA-4, or41, is needed for lympho-Japan
cyte homing to bone marrow and during B cell entry
into spleen white pulp (Berlin-Rufenach et al., 1999; Lo
et al., 2003). After transendothelial migration or releaseSummary
in the marginal sinus of spleen, CCR7 ligands attract
T lymphocytes toward the T cell area, while CXCL13Chemokines guide lymphocytes from blood to sec-
produced in follicular dendritic cell-containing B cellondary lymphoid organs by triggering integrin-depen-
follicles attracts B lymphocytes into this microenviron-dent firm adhesion under vascular flow and directed
ment (Cyster, 1999).migration of T and B lymphocytes within lymphoid
Chemokine receptors belong to the superfamily of Gitissue. Here, we analyze the roles of DOCK2, a mam-
protein-coupled receptors (GPCR). Chemokine receptormalian homolog of Caenorhabditis elegans CED-5 and
signaling pathways, which cause integrin activation, cellDrosophila melanogaster Myoblast City, and phospho-
polarization, and directed cell movement, are not com-inositide-3-kinase (PI3K) during lymphocyte recircula-
pletely understood in lymphocytes. Studies in a varietytion. DOCK2 mediated efficient lymphocyte migration
of cell types identified the small GTPase Rac as a keyin a largely PI3K-independent manner, although a
modulator of F-actin polymerization and lamellipodiaminor, PI3K-dependent pathway for migration was ob-
formation, a prerequisite for cell migration (Etienne-served in wild-type and DOCK2-deficient lympho-
Manneville and Hall, 2002). Rac, like all small GTPases,
cytes. In T cells, this residual migration depended
functions as a molecular switch, alternating between a
mainly on PI3K, whereas other PI3K isoforms were GTP-loaded “active” form and a GDP bound “inactive”
implicated in B cells. In vitro adhesion assays and form. GTP loading (activation) of Rac requires specific
intravital microscopy of lymphoid organ vasculature Rac guanine exchange factors (GEF) (Etienne-Manne-
uncovered an unexpected defect in integrin activation ville and Hall, 2002). In lymphocytes, chemokine-medi-
in DOCK2/ B cells, whereas lack of DOCK2 did not ated Rac activation depends strongly on DOCK2, a
affect chemokine-triggered integrin activation in T cells. member of the CDM (CED-5 in C. elegans, DOCK180 in
DOCK2 and PI3K thus play distinct roles during T man and Myoblast city in D. melanogaster) protein family
and B cell integrin activation and migration. (Fukui et al., 2001). CDM proteins are evolutionarily con-
served regulators of cytoskeletal dynamics by acting
Introduction upstream of Rac during phagocytosis and cell migration
(Brugnera et al., 2002; Cote and Vuori, 2002; Reif and
Naive lymphocytes continuously migrate or “home” Cyster, 2002). DOCK2 binds ELMO-1 and ELMO-2,
from blood to secondary lymphoid organs (SLO) such adaptor proteins containing putative pleckstrin homol-
as spleen, peripheral and mesenteric lymph nodes (PLN ogy (PH) domains (Sanui et al., 2003b). DOCK2-deficient
and MLN, respectively), and gut-associated lymphoid lymphocytes show no detectable chemokine-induced
tissue including Peyer’s patches (PP) (von Andrian and Rac activation and migrate poorly to homeostatic che-
mokines (Fukui et al., 2001). A residual lymphoid struc-
ture with clearly separated T and B cell areas is nonethe-*Correspondence: jstein@cnb.uam.es
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less found in SLO of DOCK2/ mice (Fukui et al., 2001). pendent, DOCK2-dependent pathway, although PI3K
Such a structure is not present in mice genetically defi- activity appears to be required for optimal migration at
cient in CCL19 and CCL21 or CXCL13, suggesting a low chemokine concentrations. In vitro studies and data
DOCK2-independent pathway for lymphocyte migration from intravital microscopy (IVM) of PLN and PP venules
(Reif and Cyster, 2002). revealed differences in signaling pathways between T
Recent studies in neutrophils and the slime mold Dyc- and B cells during chemokine-mediated integrin activa-
tostelium identified PI3K as a key player during cell mi- tion. Whereas DOCK2 does not have a role in integrin-
gration (Comer and Parent, 2002; Hirsch et al., 2000; Li dependent T cell adhesion, integrin activation is defec-
et al., 2000; Ridley et al., 2003; Sasaki et al., 2000). tive in DOCK2/ B cells.
Although PI3K and its product, phosphatidylinositol-
(3,4,5)-triphosphate (PIP3), are not directly involved in Results
sensing directionality, consolidation of a persistent lead-
ing edge is compromised in cells lacking PI3K activity. DOCK2-Deficient Lymphocytes Have a Residual,
As an example, neutrophils lacking PI3Kmigrate slowly PI3K-Dependent Migration
and frequently change direction (Hannigan et al., 2002). Although hypocellular, lymphoid organs of DOCK2/
The precise role of PI3K during physiological lympho- mice show a residual structure with separate T and B cell
cyte recirculation has not been studied thoroughly. Lym- areas (Fukui et al., 2001). Detailed analysis of DOCK2/
phocytes express various PI3K isoforms (Curnock et lymphocytes confirmed residual migration (20% of con-
al., 2002), and PIP3 is formed rapidly after chemokine trol lymphocytes) to homeostatic chemokines (Figure
stimulation of lymphocytes (Constantin et al., 2000). 1A). When the chemokine gradient was disrupted, mi-
Studies using a leukemic T cell line transfected with gration of DOCK2-deficient lymphocytes decreased to
dominant-negative forms of PI3K and p85 suggest a near-background level, confirming that the migration
role for both isoforms in migration to CXCL12 (Curnock observed was not due to chemokinesis (not shown).
et al., 2003). Furthermore, chemotaxis of murine lympho- Expression of CCR7 and adhesion molecules was simi-
cytes and human PBL to this chemokine is partially lar between control and DOCK2-deficient lymphocytes
blocked by treatment with Wortmannin (Wn), a pharma- (Supplemental Figure S1 available online at http://www.
cological inhibitor of all PI3K isoforms (Stein et al., 2003; immunity.com/cgi/content/full/21/3/429/DC1/).
Vicente-Manzanares et al., 1999). In agreement with previous results (Fukui et al., 2001),
It is currently unclear if and to what extent DOCK2 short-term homing (2 hr) of adoptively transferred
and PI3K interact to mediate lymphocyte migration. Acti- DOCK2-deficient lymphocytes to PLN, MLN, and PP
vated PI3K induces DOCK180 translocation to the was strongly impaired compared to control cells (Figure
plasma membrane, albeit without increasing RacGEF 1B). Detailed histological analysis of PLN sections none-
activity (Kobayashi et al., 2001). In addition, ELMO-1 theless revealed residual migration of DOCK2/ lym-
and ELMO-2 contain PH domains that potentially inter- phocytes into lymphoid tissue (Figure 1C). In spleen,
act with phosphoinositides (Brugnera et al., 2002). Al- although most DOCK2/ lymphocytes were found out-
though PKB activation is unaltered in DOCK2-deficient
side lymphoid tissue, a small fraction of cells was con-
lymphocytes (Fukui et al., 2001), it is thus conceivable
sistently observed within white pulp (Figure 1D). Lack of
that DOCK2 interacts downstream of PI3K signaling
DOCK2 did therefore not completely abolish lymphocyte
pathways.
accumulation in SLO.In addition to its role during migration, DOCK2 has
These observations prompted us to investigate thealso been suggested to participate in chemokine-medi-
molecular basis for DOCK2-independent migration. Inated integrin activation (Nishihara et al., 2002; Reif and
these and subsequent experiments, we analyzed T andCyster, 2002). Rac activity was linked to augmented
B cell behavior separately. As predicted, residual migra-integrin-mediated adhesion in some (D’Souza-Schorey
tion of both purified control and DOCK2/ T cells toet al., 1998; Gu et al., 2003; Zhang et al., 1999), but
homeostatic chemokines was almost completely abol-not all studies (Shimonaka et al., 2003). Recent findings
ished by pertussis toxin (PTX), a Gi inhibitor (Figure 2).suggest instead a role for the small GTPases RhoA and
In contrast, whereas pharmacological inhibition of PI3KRap1 during chemokine-induced integrin activation in T
activity by Wn reduced control T cell migration to 100 nMlymphocytes, and constitutively active Rap1 increases
CCL19 and CCL21 by only 29% and 35%, respectively,both integrin affinity and avidity (Giagulli et al., 2004;
migration of DOCK2/ T cells was reduced by 73%Katagiri et al., 2003; Shimonaka et al., 2003). In a human
and 87%, respectively (Figure 2A). A similar result wasleukemia cell line, DOCK2 was found to interact with
obtained when we compared the effect of Wn on migra-the adaptor protein CrkL, which in turn binds C3G, a
tion to CXCL12 (52% inhibition of control T cell migrationRap1 GEF (Nishihara et al., 2002); we were nonetheless
versus 80% in DOCK2/T cells; Figure 2A). Comparableunable to reproduce the interaction between DOCK2
results were obtained with Ly294002, an unrelated PI3Kand CrkL (Sanui et al., 2003b). The roles of DOCK2-
inhibitor (not shown).induced Rac activity and a potential DOCK2-CrkL-C3G-
We next studied the combined effect of DOCK2 defi-Rap1 pathway during chemokine-triggered integrin acti-
ciency and PI3K inhibition on T cell homing. DOCK2/vation in lymphocytes thus remain controversial.
T cells were treated for 2 hr with Wn and, together withBy using inhibitor-treated lymphocytes or cells defi-
untreated DOCK2/ T cells, were allowed to home forcient in DOCK2 and/or PI3K, we examined the relative
4 hr in wild-type recipients. The longer homing periodimportance of DOCK2 and PI3K during physiological T
was chosen to permit greater accumulation of DOCK2/and B cell homing. Our findings suggest that most T
and B cell migration is mediated by a largely PI3K-inde- T cells in lymphoid tissue. Wn treatment further reduced
DOCK2 and PI3K in Lymphocyte Homing
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Figure 1. Residual Migration of DOCK2/ Lymphocytes to Homeostatic Chemokines
(A) Chemotaxis of control (white bars) and DOCK2/ lymphocytes (black bars) to medium (MED) or 100 nM CCL21, CCL19 and CXCL13 (n 
7; *p  0.05 as compared to medium control). Migration of DOCK2/ lymphocytes to each chemokine was significantly lower than of control
cells (p  0.05).
(B) Homing ratio (see Experimental Procedures) of DOCK2/ versus DOCK2/ lymphocytes in blood (BL), PLN, MLN, PP, and spleen (SPL)
after homing assay (2 hr). Each circle represents ratios of individual mice (n  2).
(C) PLN cryostat section (40 objective) after homing assay. MECA-79 was used as a marker for HEV.
(D) Spleen cryostat section (20 objective) after homing assay. MECA-367 was used as a marker for marginal zone sinus-lining cells.
Representative DOCK2/ cells inside lymphoid tissue are marked with arrowheads.
the already impaired DOCK2/ T cell homing to SLO for T cells, DOCK2-independent B cell migration re-
quired PI3K activity.(Figure 2B). In PLN sections, Wn-treated DOCK2/
T cells were almost exclusively associated with MECA-
79-reactive tissue, a marker for HEV (Figure 2C). In PI3K Is Involved in Chemokine-Induced PKB
spleen, Wn treatment abrogated the residual migration Phosphorylation and Migration of T, but Not B, Cells
of DOCK2/ T cells into white pulp (Figure 2D). To determine the PI3K isoforms involved in T and B cell
The existence of two pathways for lymphocyte migra- chemotaxis, we studied lymphocytes deficient in PI3K,
tion, one mediated by DOCK2 and one by PI3K, raised which is directly activated by G subunits of GPCR
the question whether distinct lymphocyte subsets pref- (Stephens et al., 1994). As a functional readout for PIP3
erentially used one pathway or the other. Control, production, we first analyzed PKB phosphorylation in
DOCK2/, or Wn-treated T cells that had migrated to chemokine-stimulated PI3K/ T and B cells. CCL21-
CCL21 were analyzed by flow cytometry. In all experi- induced PKB activation in PI3K/ T cells was greatly
ments analyzed, migrated cells were L-selectinhigh and reduced compared to control T cells, whereas no differ-
CD44low, corresponding to bona fide naive T cells (not ence was observed between control and PI3K/ B
shown). cells (Figure 3A). We nonetheless found no significant
When we analyzed migration of control and DOCK2/ difference in migration of PI3K/ T cells compared to
B cells, we observed residual DOCK2/ B cell migration control T cells at concentrations of 100 nM CCL21 or
at high CXCL13 concentrations (30% of control B cell higher (Figure 3B). Only at the lowest CCL21 concentra-
migration; Figure 2E): this was completely abrogated tion tested (50 nM), we consistently detected a signifi-
when DOCK2/ B cells were pretreated with Wn, cant reduction (2-fold) in the number of migrated
whereas control B cell migration was reduced only 40% PI3K/ T cells (Figure 3B), despite similar expression
of CCR7 on both populations (Supplemental Figure S2).after this treatment (Figure 2E). We conclude that, as
Immunity
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Figure 2. PI3K Mediates Residual Migration of DOCK2/ Lymphocytes
(A) Chemotaxis of control and PTX-or Wn-treated DOCK2/ T cells to medium (white bars) or 100 nM CCL21, CCL19, and CXCL12 (black
bars) (n 4, *p 0.05 as compared to medium control). Migration of DOCK2/ T cells was significantly lower than of control T cells (p 0.05).
(B) Homing ratio of control and Wn-treated DOCK2/ T cells after homing assay (4 hr).
(C) PLN cryostat section (40 objective) after homing assays (n  3).
(D) Spleen cryostat section (20 objective) after homing assay.
(E) Chemotaxis of control and Wn-treated control and DOCK2/ B cells to medium (white bars) and 250 nM CXCL13 (black bars) (n  3,
*p  0.05 as compared to medium control). Migration of DOCK2/ B cells was significantly lower than of control B cells (p  0.05).
This mild reduction in CCL21-mediated T cell migra- generated mice lacking both DOCK2 and PI3K.
DOCK2/PI3K/ T cells did not migrate in vitro totion was also reflected in short-term (2 hr) homing
assays. Accumulation of PI3K/ T cells in SLO was 100 nM CCL21 (Figure 4A), CCL19 or CXCL12 (not
shown). In some experiments, residual migration wasreduced 15%–30% compared to control cells (Figure
3C). In spleen sections, PI3K/ T cells accumulated nonetheless observed in DOCK2/PI3K/ T cells at
increased CCL21 concentrations (30% of migration lev-within lymphoid tissue, similar to control T cells (not
shown). When we quantified the relative distribution of els of DOCK2/ T cells at 250 nM CCL21; not shown).
In contrast, migration of double-deficient B cells wastransferred control and PI3K/ T cells inside and out-
side of MECA-367-positive sinus-lining cells, however, a not further diminished in comparison to DOCK2/ B
cells (Figure 4A).higher percentage of PI3K/ T cells was found outside
splenic white pulp as compared to control T cells (46% We next performed four h-homing assays comparing
DOCK2/ to DOCK2/PI3K/ T cells. Similar to ourPI3K/ T cells versus 35% for control T cells; n 1479
and 1348 cells, respectively, from seven spleen sections observations using Wn, homing to all SLO was further
impaired in DOCK2/PI3K/ T cells compared toin two independent experiments).
In contrast, PI3K/ B cells migrated comparably to DOCK2/ T cells (Figure 4B). When analyzing sections
from PLN and spleen, we observed that mostcontrol B cells, even at the lowest chemokine concentra-
tions at which migration could be reproducibly detected DOCK2/PI3K/ T cells were unable to migrate into
lymphoid tissue (Figures 4C and 4D), although inhibition(Figure 3D). Taken together, these data suggest that
PI3K-dependent B cell chemotaxis was not mediated appeared less complete than in Wn-treated DOCK2/
T cells.by PI3K.
Lack of DOCK2 and PI3K Almost Completely DOCK2 and PI3K Participate in CCL21-Induced
T Cell Polarization and Actin PolymerizationAbolishes T Cell Migration In Vitro and In Vivo
To test whether the residual Wn-sensitive chemotaxis In response to chemokines, T cells acquire a polarized
cell morphology with a leading edge where chemokinein DOCK2/ T cells depended on PI3K activity, we
DOCK2 and PI3K in Lymphocyte Homing
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Figure 3. PKB Phosphorylation, Migration, and Homing of PI3K/ Lymphocytes
(A) Purified control and PI3K/ T and B cells were stimulated with 100 nM CCL21 or 250 nM CXCL13, and phosphorylated PKB (p-PKB)
detected as described in the Experimental Procedures.
(B) Chemotaxis of control (white diamonds) and PI3K/ (black diamonds) T cells to CCL21 (n  5, *p  0.05 compared to PI3K/ T cells).
(C) Homing ratios of PI3K/ versus PI3K/.T cells after two h-homing assays (n  5). Homing was significantly reduced to PLN, MLN and
spleen (p  0.05).
(D) Chemotaxis of control (white bars) and PI3K/ (black bars) B cells to medium (MED), CXCL13, and CXCL12. No significant differences
in migration were found between both populations (*p  0.05 compared to medium).
receptors and intracellular molecules, such as talin ac- was slightly reduced in the absence of PI3K (Figure 5B).
In line with previous observations (Fukui et al., 2001),cumulate, and a uropod, where some adhesion mole-
cules (CD44, ICAM-3) and myosin are found (Manes et DOCK2/ T cells have greatly impaired F-actin forma-
tion after CCL21 stimulation. Residual F-actin formational., 2003).
We performed polarization experiments to assess was nonetheless consistently observed in these cells,
whereas F-actin polymerization was completely absenthow DOCK2 and/or PI3K deficiency affected the ability
of T cells to polarize in response to chemokine. CCL21- in DOCK2/PI3K/ T cells (Figure 5B). These data
implied that both DOCK2 and PI3K participate instimulated control T cells acquired a polarized cell shape,
with clear segregation of talin to the leading edge and of F-actin formation and polarization during chemokine
stimulation of T cells.CD44 to the uropod (Figure 5A). PI3K/ T cells showed
clear segregation of talin and CD44 in response to CCL21 We also quantified CXCL13-induced F-actin polymer-
ization in B cells. As reported (Fukui et al., 2001), lack(Figure 5A), although under these conditions, fewer cells
with a polarized phenotype were observed compared of DOCK2 greatly reduced F-actin formation, whereas
PI3K deficiency did not alter CXCL13-induced F-actinto control T cells (54% 	 10% control versus 25% 	
6% PI3K/ T cells; mean 	 SD). DOCK2/ T cells compared to control B cells (Figure 5B).
polarized poorly in response to CCL21 (Figure 5A), al-
though individual polarized DOCK2/ T cells were ob- B, but Not T, Cells Require DOCK2 for Efficient
Integrin Activationserved occasionally. In contrast, we found that DOCK2/
PI3K/ T cells were completely unable to polarize (Fig- In addition to lymphocyte migration, CCL21 binding to
CCR7 also induces activation of LFA-1 and 4 integrinure 5A).
Cell polarization requires Rac-dependent actin poly- adhesion receptors (von Andrian and Mackay, 2000).
Since DOCK2 is immediately downstream of chemokinemerization (Devreotes and Janetopoulos, 2003). We
found that chemokine-induced F-actin formation in T cells receptor activation, we wanted to determine whether
Immunity
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Figure 4. Strongly Impaired Migration of DOCK2/PI3K/ T Cells In Vitro and In Vivo
(A) Chemotaxis of DOCK2/ and DOCK2/PI3K/ T and B cells to medium (white bars) or 100 nM CCL21 and 250 nM CXCL13 (black bars)
(n  3, *p  0.05 as compared to medium control).
(B) Homing ratios of DOCK2/PI3K/ versus DOCK2/ T cells in four h-homing assays (n  5). Homing was significantly reduced to PLN,
MLN, and spleen (p  0.05).
(C) PLN cryostat section of after adoptive transfer experiments (40 objective).
(D) Spleen cryostat section of after adoptive transfer experiments (20 objective).
DOCK2 deficiency also affected T cell integrin activa- to higher surface integrin levels in these cells (Supple-
mental Figure S1).tion. In static adhesion assays, we observed no dif-
ferences in CCL21-induced adhesion of control and Since maximal adhesion in static adhesion assays is
only observed 3 min after chemokine addition, it wasDOCK2/ T cells to the 41 ligand VCAM-1 (2.5 
g/ml)
and ICAM-1 (4 
g/ml) (Figure 6A). Similar results were unclear whether rapid (1 s) integrin activation, as oc-
curs in SLO HEV, was also affected in DOCK2/ T cells.obtained when ICAM-1 was coated at 1 
g/ml (not
shown) and when adhesion was induced with PMA, We therefore used IVM of murine PLN vasculature to
observe adhesive interactions between adoptively trans-CXCL12, and CCL19 (Supplemental Figures S3A and
S3B). Background adhesion in absence of chemokine ferred cells and endothelium in vivo and in real time (von
Andrian and M’Rini, 1998). DOCK2/ T cells were foundwas slightly increased in DOCK2/ T cells, possibly due
DOCK2 and PI3K in Lymphocyte Homing
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Figure 5. DOCK2 and PI3K Participate in Chemokine-Induced T Cell Polarization and Actin Polymerization
(A) Phase contrast and immunofluorescent images of CCL21-stimulated control, PI3K/, DOCK2/, and DOCK2/PI3K/ T cells. Original
magnification 63.
(B) F-actin polymerization after CCL21 (100 nM) or CXCL13 (250 nM) stimulation in control, PI3K/, DOCK2/, and DOCK2/PI3K/ T
and B cells. One representative experiment of three is shown.
to adhere normally inside PLN venules (Figure 6B); this DOCK2/ B cells in static adhesion assays. On plates
coated with 4 
g/ml ICAM-1, we observed an unex-adhesion was blocked by prior PTX or anti-LFA-1 mAb
pretreatment (not shown). When quantified, no signifi- pected, severe defect of CXCL13-induced DOCK2/ B
cell adhesion (Figure 7A) despite comparable chemo-cant differences were observed between control and
DOCK2/ T cells either in rolling (not shown) or sticking kine receptor and integrin expression levels (Supple-
mental Figure S1). A similar adhesion defect was ob-fractions (Figure 6C).
To examine the possibility that some or all firm adhe- served for adhesion to MAdCAM-1 (5 
g/ml) and
VCAM-1 (0.5 
g/ml) (Figure 7A). Lack of adhesion tosion of DOCK2/ T cells was mediated by PI3K-trig-
gered LFA-1 clustering (Constantin et al., 2000), we com- ICAM-1 and MAdCAM-1 was also observed after stimu-
lation with ligands for CXCR4, CXCR5, and PMA (Figurepared adhesion of control and Wn-treated DOCK2/ T
lymphocytes in PLN vessels. No differences were ob- 7B, and not shown). The adhesion defect to ICAM-1,
MAdCAM-1, and VCAM-1 could be, at least partially,served in rolling (not shown) and sticking fractions of
these populations (Figure 6D). Similar results were ob- overcome by increasing ligand coating concentration
(Figure 7A). Under these conditions, residual adhesiontained when we compared DOCK2/ and DOCK2/
PI3K/ T cell adhesion in PLN vessels (not shown). of DOCK2/ B cells to ICAM-1 was dependent on PI3K
activity (Supplemental Figure S3C).Static adhesion assays on ICAM-1 (10 
g/ml) confirmed
that DOCK2/ T cell adhesion was independent of PI3K We used IVM to test whether the observed defect
of DOCK2/ B cells to efficiently activate integrinsactivity or chemokine used for activation (Supplemental
Figure S3B). These results suggest that in T cells, was reflected under physiological conditions. In PLN
venules, we observed virtually no firm adhesion ofDOCK2 and PI3K are not involved in CCR7-mediated
integrin activation in SLO venules. DOCK2/ B cells (Figure 7C), although they showed
normal rolling interactions (not shown). Firm arrest inWe next studied integrin activation in control and
Immunity
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Figure 6. Normal Chemokine-Induced Integrin Activation in DOCK2/ T Cells
(A) Static adhesion assays of DOCK2/ and DOCK2/ T cells to slides coated with ICAM-1 (4 
g/ml) or VCAM-1 (2.5 
g/ml). Adherent cells
were counted at 0 (white bars) and 3 min (black bars) after CCL21 addition (final concentration 1 
M; n  3, *p  0.05 as compared to 0 min).
(B) TRITC-labeled adoptively transferred DOCK2/ (top) and DOCK2/ T cells (bottom) firmly adhere inside PLN venules (labeled green).
(C) Sticking fractions (see the Experimental Procedures) of DOCK2/ and DOCK2/ T cells in PLN vessels. No significant differences were
observed between both cell populations (n  4 mice/six venules).
(D) Sticking fractions of control DOCK2/ and Wn-treated DOCK2/ T cells in PLN microcirculation. No significant differences were observed
between both cell populations (n  3 mice/six venules).
PP venules, which requires chemokine-induced activa- (Giagulli et al., 2004). Translocation of PKC in DOCK2/
B cells was comparable to control B cells (Figure 7E).tion of 47 and LFA-1(von Andrian and Mackay, 2000),
was reduced by 58% 	 19% (Figure 7C) in DOCK2/ Although we were unable to measure affinity upregula-
tion in control and DOCK2/ B cells (not shown), im-B cells compared to control B cells, despite normal
rolling (not shown). These data indicate that B cell- mune fluorescence analysis showed comparable LFA-1
clustering in both populations (Figure 7F).expressed DOCK2 is important for chemokine-triggered
physiological integrin activation.
Chemokine-induced integrin clustering and affinity Discussion
upregulation depends on a signaling network involving
the small GTPases RhoA and Rap1 (Dustin et al., 2004; The data presented here point to divergent functions
of DOCK2 and PI3K during chemokine-induced signalLaudanna et al., 2002). We performed a biochemical
comparison of these proteins in chemokine-stimulated transduction pathways between T and B cells. We con-
clude that (1) DOCK2, even in absence of measurablecontrol and DOCK2/B cells. In both populations, RhoA
and Rap1 activation were clearly observed after chemo- PI3K activity, is sufficient to mediate robust T and B cell
migration in vitro and in vivo. (2) A minor PI3K-dependentkine stimulation, although the latter at reduced levels
(Figure 7D). Chemokines also induce PKC membrane pathway for lymphocyte migration exists, which involves
mainly (but not exclusively) PI3K in T cells and othertranslocation, a process required for integrin clustering
DOCK2 and PI3K in Lymphocyte Homing
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Figure 7. Impaired Integrin Activation in DOCK2/ B Cells
(A) Static adhesion assays of control and DOCK2/ B cells to slides coated with ICAM-1 (4 and 10 
g/ml; n  3), MAdCAM-1 (5 and 10 
g/
ml; n  3–4) or VCAM-1 (0.5 and 2.5 
g/ml; n  3). Adherent cells were counted at 0 (white bars) and 3 min (black bars) after CXCL13 addition
as in Figure 6A.
(B) Static adhesion assays of control and DOCK2/ B cells to slides coated with ICAM-1 (4 
g/ml; n  3). Adherent cells were counted at 0
(white bars) and 3 min (black bars) after chemokine or 10 min after PMA addition (final concentration 50 ng/ml) as in Figure 6A.
(C) Firm adhesion of control and DOCK2/ B cells in PLN and PP vessels (n  3 for each). Control and DOCK2/ B cell adhesion was
determined as described in the Experimental Procedures.
(D) Chemokine-induced RhoA and Rap1 activation in control and DOCK2/ B cells. B cells were stimulated with 62.5 nM CXCL12 or 250 nM
CXCL13 for indicated times.
(E) Membrane translocation of PKC in control and DOCK2/ B cells. B cells were stimulated with 0.5 
M CXCL13 for indicated times.
Abbreviations: M, membrane fraction; C, cytoplasm fraction.
(F) Immunofluorescent staining of LFA-1 on control-and CXCL13-treated control and DOCK2/ B cells. CXCL13 induced similar LFA-1 cluster
formation in both populations (bar  10 
m).
PI3K isoforms in B cells. (3) Physiological T cell integrin tion supports the idea of a pivotal role of PIP3 in leading
edge stabilization, perhaps by creating docking sitesactivation does not require DOCK2 and/or PI3K activity.
(4) DOCK2 is required for efficient B cell integrin activa- for direction-sensing molecules such as PIX (Li et
al., 2003).tion in vitro and in vivo.
We have previously shown a central role for DOCK2 The relative contribution of PI3K during physiological
lymphocyte homing has not been extensively addressedduring lymphocyte migration (Fukui et al., 2001). Here,
we analyzed lymphocyte migration in more detail and in previous studies. Our findings suggest that in T cells,
in contrast to neutrophils and Dyctostelium, PI3K playsdemonstrate a DOCK2-independent role for PI3K. PI3K
activity is required for migration in neutrophils and Dyc- a less important role during chemokine-induced lym-
phocyte migration. Rather, efficient T cell migration re-tostelium, in which the cell biology of migration has been
most extensively studied (Chung et al., 2001; Devreotes lies on a largely PI3K-independent mechanism involving
DOCK2, which is not expressed in neutrophils (Nishiharaand Janetopoulos, 2003; Ridley et al., 2003). In both
cell types, PIP3 accumulates at the leading edge during et al., 1999). Our data nevertheless provide evidence
that at low CCL21 concentrations, PI3K is required formigration (Devreotes and Janetopoulos, 2003; Ridley
et al., 2003). Although PI3K-deficient neutrophils still optimal T cell chemotaxis. It is also interesting to note
that we consistently found a stronger blocking effect ofpolarize in response to chemoattractant, the leading
edge is often not correctly oriented toward the source Wn on T cell migration to CXCL12, whose receptor
CXCR4 (in contrast to CCR7) is expressed at relativelyof chemoattractant (Hannigan et al., 2002). This observa-
Immunity
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low levels on T cells. Thus, it appears that in the pres- of how this occurs is still not well defined, and the rela-
tionship between DOCK2, PI3K and Rap1 during trans-ence of a weak signal, either because of low ligand
concentration or low receptor numbers, PIP3 increases migration needs to be further analyzed. It is possible
that (prolonged) Rap1 activation might be impaired inT cell migration efficiency. Alternatively, specific lym-
phocyte subsets, such as naive and memory T cells, absence of DOCK2 or that Rap1 activation positively
regulates Rac activity, as has been recently observedmight use DOCK2 or PI3K pathways differentially. Al-
though our preliminary analysis indicated that bona fide in neurons (Maillet et al., 2003).
An unexpected finding was the B cell-restricted defectT cells can employ either pathway, a more detailed anal-
ysis on DOCK2 and PI3K expression in various lympho- in chemokine-induced integrin activation in absence of
DOCK2. Integrin activation (or lack of it) was indepen-cyte subsets may be necessary. Of note, PI3K inhibitors
efficiently blocked T cell migration to CCL5 (Turner et dent of the chemokine used, which argues for converg-
ing signaling pathways triggered by different chemokineal., 1995), which attracts mainly memory T cell subsets.
In T cells, PI3K-dependent migration is mainly me- receptors. Integrin avidity is regulated by clustering and/
or affinity upregulation (Dustin et al., 2004). Our datadiated by PI3K, in contrast to B cells. Thymocyte
development and T cell activation are also impaired in indicate that chemokine-induced LFA-1 clustering is not
significantly affected by lack of DOCK2, which is in linePI3K-deficient T cells, whereas no effect on B cell de-
velopment or activation was detected in these animals with comparable RhoA activation and PKC transloca-
tion, both required for integrin clustering (Giagulli et al.,(Rodriguez-Borlado et al., 2003; Sasaki et al., 2000).
PI3K function thus appears to be restricted to T cells. 2004). Residual adhesion of DOCK2/ B cells at high
ICAM-1 densities was dependent on PI3K activity, ar-In contrast, B, but not T, cell development and prolifera-
tion is severely affected in p85-deficient mice (Fruman guing that residual adhesion depended on LFA-1 clus-
tering (Constantin et al., 2000); likewise, clustering of 4et al., 1999; Suzuki et al., 1999), raising the possibility
that class Ia PI3K isoforms may also play a role during integrins may be responsible for adhesion at high ligand
density. Although we have not been able to directlyphysiological B cell migration.
Our data suggest that DOCK2 and PI3K activity, and measure integrin affinity changes in chemokine-stimu-
lated control or DOCK2/ B cells, defective integrin-as a consequence, Rac activation, are not required for
integrin activation during T cell homing. Increased adhe- mediated adhesion could be due to reduced affinity
upregulation. This is also supported by reduced adhe-sion of T cells expressing a constitutively active form
of Rac could be due to increased cell spreading and sion of DOCK2/ B cells in SLO venules, a process
requiring integrin affinity changes (Giagulli et al., 2004).subsequent shear resistance, rather than primary integ-
rin activation (D’Souza-Schorey et al., 1998; Zhang et al., Alternatively, integrin anchorage to the cytoskeleton
may be weakened in DOCK2/ B cells.1999). Although IVM analysis did not reveal a noticeable
tendency of adherent DOCK2/ T cells to detach more The molecular basis for impaired integrin activation
in DOCK2/ B cells is currently unknown. GTP-RhoA,rapidly than control T cells in the PLN microcirculation
(not shown), we cannot exclude a reduced shear resis- GTP-Rap1, and PKC translocation were all observed
after chemokine stimulation, although GTP-Rap1 levelstance in the absence of DOCK2.
Analogous to DOCK180-CrkII complex formation, an appeared reduced in absence of DOCK2. Interestingly,
Rap1 activation does not necessarily translate intoassociation of DOCK2 with the CrkII analog CrkL was
reported (Nishihara et al., 2002); CrkL in turn interacts increased integrin binding. A recent report shows
that a nonmyristoylated splice variant of the RapGEFwith C3G, a Rap1 GEF. However, we were not able to
coimmunoprecipitate DOCK2 and CrkL when overex- RasGRP2 (also known as CalDAG-GEFI), which is highly
expressed in spleen and PBL (Kawasaki et al., 1998), ispressed in a cell line, despite detecting readily DOCK2-
ELMO and CrkL-C3G interactions under similar condi- regulated by F-actin (Caloca et al., 2004). Upon induction
of F-actin formation, RasGRP2 translocates to thetions (Sanui et al., 2003b). In addition, CrkL-deficient
mice do not appear to have an obvious defect in lympho- plasma membrane where it mediates Rap1 activation.
In absence of F-actin formation, Rap1 activation occurscyte homeostasis (Peterson et al., 2003). The observa-
tion that Rap1-dependent LFA-1 translocation at immu- in the cytoplasm, albeit without inducing integrin activa-
tion (Caloca et al., 2004). It is therefore possible that innological synapses is not affected in DOCK2/ T cells
(Katagiri et al., 2003; Sanui et al., 2003a), together with B cells, Rac induced F-actin creates docking sites for
RasGRP2 (or other GEFs of the Rho family), resulting inthe normal chemokine-induced integrin activation re-
ported here, argues for comparable Rap1 function in GTP-Rap1 formation at the membrane, whereas Rap1
activation in T cells might be regulated by F-actin-inde-T cells lacking DOCK2. In preliminary experiments, we
have observed GTP-Rap1 in DOCK2/ T cells (not pendent GEFs. A subset-specific analysis of expression
and activation patterns of GEFs for small GTPases willshown); however, more detailed studies will have to ex-
amine kinetics and efficiency of chemokine-induced be necessary to critically examine this hypothesis.
In summary, we found that T and B cell polarization,Rap1 activation in DOCK2/ T cells.
Although DOCK2/ T cells adhere inside SLO ven- transmigration, and chemotaxis are essentially regulated
by a PI3K-independent DOCK2-induced Rac activationules, they do not efficiently enter lymphoid tissue, indi-
cating that under physiological conditions, T cells require mechanism. DOCK2-independent, PI3K-dependent path-
ways leading to migration, although detectable, wereDOCK2 and to a lesser extent, PI3K, for effective trans-
endothelial migration. Interestingly, overexpression of a less important in these cells; a more detailed analysis
uncovered a T cell-restricted role for PI3K. Finally,constitutively active form of Rap1 in a lymphoid cell line
is sufficient to promote cell adhesion and transmigration DOCK2 is required for chemokine-induced B cell adhe-
sion. Despite sharing common mechanisms and signal-in vitro (Shimonaka et al., 2003). The exact mechanism
DOCK2 and PI3K in Lymphocyte Homing
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Immunofluorescence Staining and LFA-1 Clustering Analysising molecules regulating lymphocyte recirculation in re-
Purified B and T cells were stimulated in suspension under stirringsponse to homeostatic chemokines, the relative contri-
with CXCL13 or CCL21 (500 nM) and immediately fixed in 1% ice-bution of individual isoforms may vary among lympho-
cold paraformaldehyde/PBS for 10 min. After labeling with anti-
cyte subsets. mouse LFA-1 mAb (10
g/ml, 30 min, 4C) and Cy3-labeled goat anti-
rat antibody (Jackson Laboratories), cells were allowed to adhere
Experimental Procedures on 0.1% poly-L-lysine-coated coverglasses (30 min, 4C), rinsed in
absolute ethanol and in PBS, and mounted in Vectashield. LFA-1
Antibodies and Reagents distribution was analyzed with a Leica confocal imaging system with
Abs against mouse L-selectin (Mel-14), 4 integrin (R1-2), 47 a 63 objective (NA 1.2) and quantified by using Image J analysis
(DATK32), LFA-1 (2D7), CXCR4 (2B11), CXCR5 (2G8), peripheral software. LFA-1 on nonstimulated cells was distributed in small dots
node addressin (PNAd) (MECA-79), and mucosal addressin intercel- with a mean area 0.31 	 0.1 and 0.28 	 0.09 
m2 for control and
lular adhesion molecule-1 (MAdCAM-1) (MECA-367) were from DOCK2/ T cells, respectively, and of 0.32 	 0.15 and 0.31 	 0.12
Pharmingen (San Diego, CA). Human CCL19-Ig was used for CCR7 
m2 for control and DOCK2/ B cells. In chemokine-stimulated
staining as described (Stein et al., 2003). Murine VCAM-1, cells, LFA-1 localized to bigger dots with a mean area of 1.75 	 1.2
MAdCAM-1, CXCL13, and CCL19 were from R&D Systems (Minne- and 2.7 	 3.7 
m2 for control and DOCK2/ T cells and of 2.86 	
apolis, MN). Murine CCL21 and CXCL12 were from Peprotech (Lon- 2.77 and 3.17 	 3.08 
m2 for control and DOCK2/ B cells. At least
don, UK). Calcein-AM, tetramethylrhodamine-5-(and-6)-isothiocya- 30 cells were analyzed per condition.
nate (5[6]-TRITC), BCECF-AM, Cell Tracker Green (CMFDA) and Cell
Tracker Orange (CMTMR) were from Molecular Probes (Eugene, Static Adhesion Assays
Oregon, USA). All mice used in this study were on the C57BL/6 back- Static adhesion assays were carried out as described (Stein et al.,
ground. 2003). ICAM-1, VCAM-1, and MAdCAM-1 were coated at indicated
concentrations for 1 hr at 37C in a humidified chamber.
Isolation of Murine ICAM-1
Mouse ICAM-1 was isolated as described for VCAM-1 (Honda et Homing Assays
al., 1994). In brief, lysates from60–70 mouse spleens were passed Lymphocytes were labeled with 0.3 
M Cell Tracker Green or 1.5
through a precolumn (Hi-trap column; Pharmacia, Uppsala, Sweden) 
M Cell Tracker Orange (45 min, 37C, 5% CO2), washed, and
coated with an isotype-matched antibody (rat IgG2a; clone HB- 10–15  106 cells of each population injected intravenously in age-
10487, specific for human IL-10) and subsequently through a column and sex-matched C57/B6 mice. After 2 or 4 hr, recipient mice were
coated with anti-mouse ICAM-1 (clone HB-233; both hybridoma killed and blood and SLO isolated. Part of the spleen and 1–2 PLN
were from American Type Culture Collection [ATCC], Manassas, were snap frozen for histology studies. Percentages of green- and
VA). Bound ICAM-1 was eluted with elution buffer (50 mM red-labeled adoptively transferred cells were analyzed by flow cy-
-octylglucoside/0.2 M acetic acid/0.5 M NaCl). Fractions were tometry in each organ. The ratio of the input population was also
quantified by comparing with recombinant ICAM-1/Fc in dot-blot determined and used as a correction factor as described (Berlin-
analysis. Rufenach et al., 1999). From these data, a homing ratio was cal-
culated for each organ: (percent inhibitor-treated or genetically
deficient adoptively transferred cells/percent control adoptivelyIsolation and Treatment of T and B Cells
Single cell suspensions were obtained from PLN, MLN, and spleens. transferred cells)  (correction factor input).
Negative selection was carried out by using magnetic beads coated
with anti-B220 or anti-Thy1.2 and anti-Mac1 (Dynal, Oslo, Norway). Immunohistology
Purity of specific subpopulations was checked by flow cytometry 8 
m cryostat sections were fixed for 10 min in 2% paraformalde-
and found to be 95% for CD4/CD8-positive cells and 90% for hyde, washed in PBS, blocked with FCS, and stained with MECA-
B220-positive cells. In some experiments, cells were treated with 79 in PLN sections or MECA-367 in spleen sections. As a secondary
0.1 
g/ml Pertussis toxin (PTX) (Sigma, St. Louis, MO), 0.5 
M Wort- Ab, biotinylated anti-ratIg (DAKO, Denmark) was used, followed by
mannin (Calbiochem, La Jolla, CA), or dimethylsulfoxide (DMSO) for Alexa350-conjugated anti-rabbitIg (Molecular Probes). Preparations
2 hr at 37C, 5% CO2. were observed using a Leica confocal microscope and analyzed by
using Leica Software.
Chemotaxis Assays
Chemotaxis assays with control, genetically deficient, or inhibitor- Polarization Assay
treated lymphocytes were carried out as described (Stein et al., Purified T cells were plated onto collagen I-coated chamber slides
2003). (Beckton-Dickinson; 40 
g/ml) and then stimulated with CCL21 (100
nM, 20 min, 37C). After washing, cells were fixed with 4% paraform-
aldehyde (15 min at RT), permeabilized with 0.1% TritonX-100 (5 min)Immunoblot Analysis
and incubated with anti-talin (Sigma) and biotin-labeled anti-CD44Purified T and B cells (3  106 cells/point) were stimulated for indi-
(Pharmingen) mAbs. Primary antibodies were detected with a Cy3-cated times with chemokines, and lysates were blotted with an anti-
labeled anti-mouse Ab (Jackson ImmunoResearch Laboratories,phospho-PKB-specific Ab (Transduction Laboratories, Lexington,
West Grove, PA) and Alexa488-labeled avidin (Molecular Probes).KY). As a control for protein loading, anti-PKB (Upstate Biotechnol-
Fluorescence and phase contrast images were recorded in a fluores-ogy, Lake Placid, NY) was used. To measure Rap1 and RhoA activa-
cence microscope (Leica Microsystems) by using a 63 objective.tion, purified B cell extracts (1.5–2  107 cells per sample) were
Eight random fields were recorded per condition and at least 400incubated with GST-Ral GDS-RBD or GST-Rhotekinin fusion pro-
cells were counted per sample. Each experiment was repeated atteins, respectively, as described (Fukui et al., 2001; Maillet et al.,
least four times. Cells showing accumulation of talin at the leading2003). For PKC translocation studies, crude membrane fractions
edge and CD44 at the uropod were scored as polarized (Gomez-were obtained from cells passed through 30 gauge needle in 50
Mouton et al., 2001).mM Tris-HCl (pH 7.5), plus a cocktail of protease and phosphatase
inhibitors. Cleared supernatant was centrifuged (55,000 rpm, 60 min,
4C) to precipitate the membrane fraction. The supernatant was Actin Polymerization
Lymphocytes were resuspended to 5  106 cells/ml in RPMI/1%collected and the precipitate resuspended in 50 mM Tris-HCl (pH
7.5), 1% Triton X-100, plus protease and phosphatase inhibitors. FCS/10 mM HEPES (pH 7.5) and kept at 37C. Before chemokine
addition, aliquots were taken out of each sample to determine base-Normalized protein amounts for each fraction were resolved in SDS-
PAGE and analyzed sequentially by blotting with anti-PKC (Santa line F-actin levels. CCL21 or CXCL13 were added to the cell suspen-
sions and aliquots were taken at indicated times and immediatelyCruz Biotechnology, Santa Cruz, CA). Anti-transferrin receptor
(Zymed, South San Francisco, CA) and anti-tubulin (Sigma) Abs fixed in 4% paraformaldehyde for 10 min. After washing with PBS,
samples were labeled with APC-conjugated anti-B220 and PerCp-were used to control purity of membrane and cytoplasm fractions.
Immunity
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conjugated anti-CD4 and anti-CD8 mAbs (Pharmingen). Samples ways controlling cell polarity and chemotaxis. Trends Biochem. Sci.
26, 557–566.were stained with FITC-Phalloidin (Molecular Probes) as a probe for
F-actin and analyzed by flow cytometry (LSR, Beckton Dickinson). Comer, F.I., and Parent, C.A. (2002). PI 3-kinases and PTEN: how
opposites chemoattract. Cell 109, 541–544.
Intravital Microscopy of Mouse PLN and PP Microvasculature
Constantin, G., Majeed, M., Giagulli, C., Piccio, L., Kim, J.Y., Butcher,
Intravital microscopy (IVM) of mouse subiliac lymph node venules
E.C., and Laudanna, C. (2000). Chemokines trigger immediate beta2
has been previously described in detail (von Andrian and M’Rini,
integrin affinity and mobility changes: differential regulation and
1998). Control, genetically deficient, or inhibitor-treated T cells la-
roles in lymphocyte arrest under flow. Immunity 13, 759–769.
beled with Calcein-AM (0.25 
M, 5 min, 37C) were injected and
Cote, J.F., and Vuori, K. (2002). Identification of an evolutionarilytheir behavior in PLN microvessels observed by using an intravital
conserved superfamily of DOCK180-related proteins with guaninemicroscope (DM-LFSA, Leica Microsystems) connected to a scien-
nucleotide exchange activity. J. Cell Sci. 115, 4901–4913.tific grade CCD camera (COHU, San Diego, CA) or a silicon-intensi-
Curnock, A.P., Logan, M.K., and Ward, S.G. (2002). Chemokine sig-fied target camera (Dage-MTI, Michigan City, IN). We used a mer-
nalling: pivoting around multiple phosphoinositide 3-kinases. Immu-cury-arc lamp as fluorescent light source. All events were recorded
nology 105, 125–136.for offline analysis (DSR-11, Sony, Madrid, Spain). In some experi-
ments, cells were labeled with TRITC (0.8 
M, 20 min, 37C), while Curnock, A.P., Sotsios, Y., Wright, K.L., and Ward, S.G. (2003). Opti-
the vascular lumen was labeled by injection of FITC-dextran (aver- mal chemotactic responses of leukemic T cells to stromal cell-
age MW of dextran: 283 kDa; Sigma). Lymphocyte behavior in lymph derived factor-1 requires the activation of both class IA and IB
node vessels was analyzed off line as described (von Andrian and phosphoinositide 3-kinases. J. Immunol. 170, 4021–4030.
M’Rini, 1998). In brief, the sticking fraction was determined as per- Cyster, J.G. (1999). Chemokines and cell migration in secondary
centage of rollers that became firmly adhered in PLN venules for lymphoid organs. Science 286, 2098–2102.
more than 20 s.
D’Souza-Schorey, C., Boettner, B., and Van Aelst, L. (1998). RacFor IVM of B cell homing to PLN, 5  106 control or DOCK2/
regulates integrin-mediated spreading and increased adhesion ofTRITC-labeled cells were injected and adherent cells were recorded
T lymphocytes. Mol. Cell. Biol. 18, 3936–3946.after 15 to 30 min. After recording adherent cells, FITC-dextran was
Devreotes, P., and Janetopoulos, C. (2003). Eukaryotic chemotaxis:injected to permit offline measurement of the intraluminal vessel
distinctions between directional sensing and polarization. J. Biol.surface. B cell adhesion was expressed as adherent cells/mm2. IVM
Chem. 278, 20445–20448.of PP venules was essentially as described (Warnock et al., 2000).
BCECF-AM and TRITC-labeled control and DOCK2/ B cells Dustin, M.L., Bivona, T.G., and Philips, M.R. (2004). Membranes as
(5–10  106 cells each) were injected simultaneously and allowed messengers in T cell adhesion signaling. Nat. Immunol. 5, 363–372.
to accumulate in PP venules for 15 to 30 min. Adhesion was mea- Etienne-Manneville, S., and Hall, A. (2002). Rho GTPases in cell
sured as in PLN experiments. biology. Nature 420, 629–635.
Fruman, D.A., Snapper, S.B., Yballe, C.M., Davidson, L., Yu, J.Y.,Statistical Analysis
Alt, F.W., and Cantley, L.C. (1999). Impaired B cell developmentData were analyzed by using InStat software (GraphPad Software,
and proliferation in absence of phosphoinositide 3-kinase p85alpha.San Diego, CA). The Student’s t test was employed for all statisti-
Science 283, 393–397.cal analysis.
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